VistaGen Therapeutics, Inc. (VTGN) has 10 open-market insider trades by 8 insiders since 2019. The most active filer is Jon S. Saxe, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Commodore Capital L.P. | 10% | — | 1 | $18.0M | 2023-08-07 |
| Shawn Singh | CEOPres | — | 1 | $204K | 2026-06-30 |
| Reid G. Adler | CLO | — | 1 | $102K | 2026-06-30 |
| Jerrold Duane Dotson | CFOVPSecretary | — | 1 | $94K | 2023-06-30 |
| VHCP Management II, LLC | 10% Owner | — | 1 | $53K | 2022-07-12 |
| Jon S. Saxe | Dir | — | 2 | $46K | 2021-03-19 |
| Jerry B. Gin | Dir | — | 1 | $18K | 2022-08-18 |
| H. Ralph Snodgrass | PRES./CHIEF SCIENTIFIC OFFICER | — | 2 | $15K | 2021-09-02 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Commodore Capital L.P. | 10% | Buy | $18.0M | 2023-08-07 |
| Jerry B. Gin | Director | Buy | $18K | 2022-08-18 |
| Reid G. Adler | CLO | Buy | $102K | 2022-08-17 |
| Shawn Singh | CEO | Buy | $204K | 2022-08-17 |
| VHCP Management II, LLC | 10% Owner | Sell | $53K | 2022-07-12 |
| Jerrold Duane Dotson | CFO & VP +1 | Sell | $94K | 2021-09-07 |
Companies that share insiders with VTGN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| H. Ralph Snodgrass | PRES./CHIEF SCIENTIFIC OFFICER | Buy | $10K | 2021-08-17 |
| Jon S. Saxe | Director | Buy | $21K | 2020-08-21 |
| H. Ralph Snodgrass | PRES./CHIEF SCIENTIFIC OFFICER | Buy | $5K | 2019-11-20 |
| Jon S. Saxe | Director | Buy | $25K | 2019-03-13 |